A Meeting of Minds
Sovereign Strategy offers experienced
guidance in this new global age.
Sovereign Strategy’s “Research for Impact and the G20: How can global health innovation drive sustainable development?” roundtable event, held on Friday 28th April 2017 at the Quadriga Forum in Berlin, Germany was organized by Sovereign Strategy and co-hosted with the following organizations: the Global Alliance for TB Drug Development (TB Alliance), Medicines for Malaria Venture (MMV), the Sabin Vaccine Institute, the Coalition for Epidemic Preparedness Innovations (CEPI), PATH (Program for Appropriate Technology in Health), the Global Health Technologies Coalition (GHTC), the Global Health Innovative Technology (GHIT) Fund, UNITAID and CARB-X.
The one-day roundtable event involved opening and closing speeches, two sessions of moderated roundtable discussions, presentations on the G20 priority foci of Antimicrobial Resistance (AMR) and pandemic preparedness, the B20 and its health initiative as well as the current project, its Call to Action (CTA) output document and discussions on how to carry it forward. The stated objective was to create a platform for cooperation and policy advocacy for an open and unique coalition of organizations leading up to and following the Berlin declaration of the G20 Health Ministers and the Hamburg Summit.
Following our “G20 Global Health Innovation” roundtable discussions in Berlin on 28th April, we were honoured to be part of the B20 Health Conference on 18th May 2017 where our Executive Chairman Alan Donnelly highlighted the importance of a mutli-stakeholder cooperation between politicians, the private sector and public private partnerships as well as NGO’s in order to address the interrelated challenges of Antimicrobial Resistance (AMR), pandemic preparedness/ response and Poverty Related Neglected Diseases (PRNDs). He joined Merck, CEPI and FIND in order to discuss ways to eliminate Neglected Tropical Diseases (NTDs) by 2020. Sovereign Strategy welcomed the attendance of Dr. Hatchett (CEPI), Dr. Stormy-Annika Mildner (B20), Dr. Harald Nusser (Novartis) and many other high-level attendees, at both our G20 Global Health Innovation event and the B20 Health Conference.
We are grateful to the B20 and its Health Initiative for this inspiring conference and the convergence, in several areas, between our Initiative and the B20.
We are appreciative of the impact that our “G20 Global Health Innovation” roundtable discussions and our Call to Action had on the final G20 Health Ministers Declaration. We welcome the good result that health will feature prominently in the high-level recommendations for an upgraded G20 partnership with Africa and specifically with countries that are part of the G20 Compact with Africa.
To learn more about the B20 Health Initiative, click here.
Our long term work with Sovereign has enabled us to build new relationships in the UK and across Europe which has expanded our influence with key decision makers.
Our experience shows that while many professional advisors make claims – Sovereign delivers.
I have worked with Sovereign over many years and have found them to be knowledgeable and professional in everything I have seen them do. They have extensive contacts and networks globally and have dealt at the highest levels of government both home and abroad.
Sovereign has built an international reputation for the quality of its strategic advice to global organisations like the FIA. Crucially, Sovereign understands the speed and nature of change in a complex business and political world